Xilio Therapeutics, Inc. — DEF 14A Filings
6 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Xilio Therapeutics, Inc. (XLO), sorted by most recent first. Each row links to the full filing on EdgarLookup. Xilio Therapeutics, Inc. has filed 6 DEF 14A documents with the SEC since 2021. To view all SEC filings by Xilio Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001193125-26-021691 | Jan 26, 2026 | Feb 23, 2026 |
| DEF 14A | DEF 14A | 0001193125-25-243037 | Oct 20, 2025 | Nov 21, 2025 |
| DEF 14A | DEF 14A | 0001558370-25-005689 | Apr 28, 2025 | Jun 10, 2025 |
| DEF 14A | DEF 14A | 0001558370-24-005762 | Apr 25, 2024 | Jun 13, 2024 |
| DEF 14A | DEF 14A | 0001558370-23-006642 | Apr 25, 2023 | Jun 8, 2023 |
| DEF 14A | DEF 14A | 0001558370-22-005974 | Apr 26, 2022 | Jun 9, 2022 |